Quick Answer: Foreign investors can use SAFE agreements and convertible notes to invest in Israeli startups, but these instruments require careful adaptation to Israeli Companies Law 1999 and the Income Tax Ordinance. A US-style Y Combinator SAFE cannot be used as-is in Israel — it needs an Israeli law annex, a board resolution, and (for secured instruments) registration with the Companies Registrar within 21 days. Tax withholding on interest defaults to 25% but most treaties reduce it to 10–15%.

Israel has more than 7,000 active startups and a venture ecosystem raising billions of dollars annually, which makes it one of the more unusual places in the world to be an angel investor. Founders are technically strong, deal pace is fast, and the exits are real. So foreign investors show up with a standard Y Combinator SAFE or a Silicon Valley convertible note template, fully expecting to close the same way they would in California.

Israeli company law doesn't work that way. The Israeli Companies Law 1999 (*Hok ha-Chevrot*) has no statutory category for the SAFE. Tax law imposes mandatory minimum interest on any loan — including instruments that look like loans. And without proper corporate resolutions, a SAFE that converts in Tel Aviv can be challenged at exactly the wrong moment: the Series A round or an acquisition. This guide covers what to sort out before you wire.

1. Overview: The Israeli Startup Investment Landscape

Early-stage investment in Israeli startups is dominated by two instruments: Convertible Loan Agreements (*Haskam Halvaat Hemara*, commonly abbreviated "CLA") and, increasingly, SAFE-style instruments adapted for Israeli law. Both allow an investor to put money into a startup today and receive equity at a future priced round, without requiring the parties to agree on a valuation now.

The Israeli startup community has broadly adopted market norms influenced by US practice — the Israel Advanced Technology Industries (IATI) and the Israel Bar Association publish model term sheets that incorporate valuation caps, discount rates, and MFN (most-favoured-nation) clauses. However, the underlying legal framework is Israeli, which creates several important differences:

  • Debt characterisation: Under Israeli tax law, any instrument that looks like a loan — even a SAFE — may be treated as debt, triggering mandatory interest rules under Section 3(i) of the Income Tax Ordinance 1961.
  • Corporate formalities: Issuing convertible instruments requires a board resolution and, in some cases, a shareholder resolution under Section 288 of the Israeli Companies Law 1999.
  • Charge registration: If the convertible instrument creates a security interest over company assets, it must be registered with the Companies Registrar (*Rasham ha-Chevrot*) within 21 days of signing — or the charge is void against a liquidator.
  • Securities law: Israeli Securities Law 1968 (*Hok Nirot Erech*) limits public offerings; private placements to fewer than 35 non-qualified investors in a 12-month period are generally exempt, but documentation must reflect this.
In Practice — Companies Registrar Filing:

If your convertible note includes a fixed or floating charge over the startup's assets (IP, bank accounts, or future receivables), the company must file Form 10 with the Companies Registrar within 21 days of signing. The filing fee is approximately NIS 990 (as of 2026). Missing this deadline means the charge is unenforceable in insolvency — a significant risk if the startup fails before the round.

A Y Combinator SAFE ("Simple Agreement for Future Equity") was designed for the US legal system and specifically for Delaware corporations. When applied to an Israeli company (*chevra*), it faces three structural challenges that require legal attention.

The first issue is classification. The Israel Tax Authority treats SAFEs as loans, not equity. That matters because Income Tax Ordinance Section 3(i) deems any interest-free loan to carry imputed interest at the "prescribed rate" — set annually by the ITA, currently around 3.27% for 2025–2026. A standard YC SAFE bears no interest. The ITA can therefore impute interest income to the company, creating a tax liability before a single share is issued.

The second issue is share issuance authority. Under Section 73 of the Israeli Companies Law 1999, the board can only issue new shares within the limits the articles of association (*takanon*) set out. If the startup's articles don't contemplate convertible instruments or haven't reserved enough authorised-but-unissued shares, conversion at a future round may require a shareholder meeting. That's slow and complicated when your co-investors are spread across three time zones.

The third issue is the simplest: the SAFE doesn't exist in Israeli law. Convertible notes and options have their own statutory categories (Section 46 and Chapter 8 of the Companies Law). The SAFE has none. Courts have treated analogous instruments as a conditional loan, an option, or something in between. A SAFE drafted under California law and executed by an Israeli company creates genuine enforceability uncertainty if the relationship breaks down before conversion.

The solution used in practice is to add an Israeli law annex (*nispach*) to the SAFE that:

  • Specifies Israeli law as the governing law for company-level matters
  • Incorporates a board resolution approving the issuance of the convertible instrument
  • Adds interest at the Bank of Israel rate (currently approximately 4.5% per annum) to satisfy Section 3(i), or obtains an advance tax ruling from the ITA confirming SAFE treatment
  • Confirms the securities law private placement exemption applies
  • Sets out which share class the SAFE converts into and at what priority
In Practice — ITA Advance Ruling:

Startups that regularly raise on SAFEs sometimes seek an advance ruling (*hachlatah merakdemet*) from the Israel Tax Authority confirming that the SAFE will not be treated as a loan for Section 3(i) purposes. The ITA typically responds within 3–6 months. For a single seed investment, this delay is usually impractical — which is why most practitioners instead add a modest interest rate (Bank of Israel base rate) to eliminate the imputed interest risk entirely.

3. Convertible Loan Agreements (CLAs) — The Israeli Standard

In the Israeli market, the Convertible Loan Agreement (*Haskam Halvaat Hemara*) is more commonly used than the SAFE at the pre-seed and seed stages. A CLA is structured as a genuine loan — it has a principal amount, a maturity date, and interest — that converts into shares when certain triggering events occur. This structure maps more cleanly onto the Israeli Companies Law and the Income Tax Ordinance, which is why Israeli lawyers prefer it for domestic deals.

A typical Israeli CLA has the following structure:

  • Principal amount: The amount invested, denominated in USD (common for foreign investors) or NIS (preferred by domestic investors for tax simplicity).
  • Interest rate: Usually the Bank of Israel base rate plus 1–2%, or a fixed rate of 5–8% per annum. Some CLAs accrue interest but do not require cash payment — interest is added to the principal and converts along with it.
  • Maturity date: Typically 18–24 months from signing. If no qualifying round has occurred by maturity, the investor may demand repayment, convert at the cap, or extend — the CLA specifies which option applies.
  • Valuation cap (*titqorah*): The maximum company valuation at which the loan converts. If the next round is priced above the cap, the investor converts as if the valuation were the cap — giving them a larger percentage of the company.
  • Discount rate (*hanahah*): Typically 10–25%. If the Series A price is NIS 10 per share and the discount is 20%, the CLA converts at NIS 8 per share, regardless of cap.
  • Qualifying round threshold: A minimum amount that must be raised in the next round before conversion is triggered — commonly set at $1 million or NIS 3.5 million.
Advertisement
In Practice — Board and Shareholder Resolutions:

Signing a CLA requires a board resolution of the Israeli company under Section 288 of the Israeli Companies Law 1999. The resolution must specifically authorise the loan and the conversion terms. If the CLA includes any preferential liquidation rights upon conversion, amending the company's articles of association requires a 75% supermajority shareholder vote under Section 20. For a startup with 3–5 founders, this is typically straightforward — but foreign investors should insist on receiving copies of signed resolutions before wiring funds.

4. Key Economic Terms to Negotiate

Whether you use a SAFE or a CLA, the economic outcome comes down to five provisions. The instrument choice matters far less than the terms inside it.

Valuation cap. This is the most important term. Negotiate a cap that reflects the company's realistic Series A valuation — typically 2x–4x the current implied value. If the cap is too high, the discount from conversion may be negligible. Israeli startup CLAs typically set caps between $2 million and $8 million for pre-seed rounds, though this varies widely by sector (deep-tech and medical device startups command higher caps).

Most-Favoured-Nation (MFN) clause. An MFN clause ensures that if the company issues a later convertible instrument with better terms (lower cap, higher discount, additional rights), your CLA is automatically amended to match. This is standard in the Israeli market and should be insisted upon if you are an early investor and later investors may negotiate harder terms.

Pro-rata rights. The right to participate in the next priced round, up to your pro-rata share of the fully-diluted capitalization. Israeli law does not automatically grant this right — it must be negotiated and included in the CLA. Without it, early investors are diluted at the Series A without any ability to maintain their percentage.

Change-of-control trigger. What happens if the company is acquired while your CLA is outstanding? The three common Israeli market solutions are: (a) automatic conversion at the cap before closing; (b) return of principal plus a 1x–2x liquidity premium; or (c) investor's choice between (a) and (b). Option (c) is the most investor-friendly. Without explicit language, the startup may argue that the CLA simply gets repaid at face value — leaving you with no equity upside despite the exit.

Information rights. Foreign investors often underestimate this. Israeli Companies Law 1999 Section 184 gives shareholders (not creditors) the right to inspect company records. While your CLA is outstanding — before conversion — you are a creditor, not a shareholder, and have no statutory inspection rights. Negotiate contractual information rights: quarterly financial statements, annual audited accounts, and prompt notice of material events.

In Practice — MFN Clause in Practice:

Suppose you invest $100,000 in an Israeli startup's CLA at a $4 million cap. Three months later, the company raises another $250,000 from a strategic investor at a $3 million cap. With an MFN clause, your CLA is automatically amended to the $3 million cap. Without it, you convert at $4 million while the later investor converts at $3 million — meaning they receive more shares per dollar. In Israeli seed rounds, where there are often multiple investors closing at different times, the MFN clause can meaningfully affect your final ownership percentage.

5. Tax Treatment for Foreign Investors

Most foreign investors are caught off-guard by how aggressively Israel taxes interest. The ITA's position is that any interest paid by an Israeli company is Israel-source income, taxable in Israel regardless of where you sit. That applies to your CLA from the moment interest starts accruing.

Interest withholding. Under Section 170 of the Income Tax Ordinance 1961, the Israeli company must withhold tax before paying interest to a foreign investor. The default rate is 25% — for individuals and for companies based in non-treaty countries alike. Most of Israel's double-taxation treaties reduce this to 10–15%. Common treaty rates:

  • United States: 17.5% (Article 11 of the US-Israel DTA, 1994)
  • United Kingdom: 15%
  • Germany: 15%
  • France: 10%
  • Canada: 15%
  • Australia: 10%

To claim a treaty rate, the foreign investor must provide the Israeli startup with a certificate of tax residence (*teudot toshavut*) issued by their home country tax authority — valid for the current tax year. The startup then applies the reduced rate and remits the tax to the ITA by the 15th of the following month.

Capital gains on conversion. The moment your CLA converts into shares, the conversion itself is not generally a taxable event under Israeli law — no cash changes hands. Capital gains tax on the investment becomes relevant when you later sell your shares. At that point, as a non-resident, you will be subject to Israel's capital gains tax under Section 91 of the Income Tax Ordinance at a rate of 25% (for individuals) on the gain. Many tax treaties reduce or eliminate this tax — the US-Israel treaty, for example, generally allows the US to tax the gains of a US-resident investor, not Israel, provided the investor holds less than 10% of the company. Verify your treaty position before investing.

Currency considerations. If your CLA is denominated in USD but the company reports in NIS, exchange rate fluctuations create book gains and losses. The ITA has issued guidance (Circular 16/2011) clarifying that exchange rate differences on foreign-currency loans between Israeli companies and foreign creditors are generally exempt from Israeli tax for the non-resident creditor — but the company may have deductible or taxable exchange-rate differences.

In Practice — Withholding Tax Process:

An Israeli startup paying quarterly interest of $5,000 to a US-based investor must: (1) obtain the investor's IRS-issued Form 6166 (US tax residency certificate) before the first payment; (2) apply the 17.5% treaty rate, withholding $875; (3) file a monthly withholding tax report (Form 161) with the ITA and remit the withheld amount by the 15th of the following month; (4) issue the investor an annual withholding certificate (*teudah al nikui bemkor*) by January 31 for the prior year. Investors who do not receive this certificate cannot claim a foreign tax credit in their home country tax return.

6. How Conversion Works in Practice

When your CLA or SAFE converts into shares, there are three possible triggers, and each plays out differently. Knowing which applies to your situation determines what documents you need and how fast it closes.

Triggering event — qualifying round. Most CLAs define a "Qualifying Financing Round" (*sevet machtziv mechashev*) as a priced round raising at least a specified minimum amount (commonly $1 million). When the startup closes this round, the CLA converts automatically on the round's closing date. The investor receives shares at the lower of the cap price and the discount price. The company's board adopts a resolution issuing the shares, the investor signs the investors' rights agreement of the new round, and the shares are registered in the company's shareholder register (*pinkass baalei hamניות*).

Triggering event — change of control. If the company is sold or merges before a qualifying round, the CLA's change-of-control clause activates. In Israeli M&A practice, the acquirer's legal team will review all outstanding convertible instruments during due diligence — any ambiguity in the trigger language will be flagged as a risk. Investors should ensure their CLAs clearly define "change of control" to include asset sales, majority share transfers, and merger transactions, not just outright acquisitions.

Triggering event — maturity. If neither a qualifying round nor an exit occurs by the maturity date, the CLA matures. At this point, the instrument typically gives the investor the right to demand repayment of principal plus accrued interest, or to convert at the cap valuation (whichever the investor prefers). Most startups will not have cash to repay — so in practice, the parties either extend the CLA by mutual agreement or the investor converts into ordinary shares at the cap. The extension is documented via a short amendment signed by both parties and authorised by a new board resolution.

Share issuance mechanics. Once conversion is triggered, the Israeli company must:

  1. Pass a board resolution authorising the allotment of shares to the investor
  2. Issue a share certificate (*teudat manieh*) or update the electronic shareholder register
  3. File a Form 7 (Report on Allotment of Shares) with the Companies Registrar within 30 days of allotment
  4. Pay the Registrar filing fee of approximately NIS 620 for up to 5 allottees (as of 2026)
  5. Update the company's internal shareholder register and cap table
In Practice — Cap Table at Conversion:

Suppose you invested $150,000 on a CLA with a $5 million cap and a 20% discount. The startup closes a Series A at a $10 million pre-money valuation, issuing preferred shares at $2.00 per share. Your discount price is $1.60 per share; your cap price is $1.00 per share (based on $5M cap divided by the fully-diluted share count). You convert at $1.00 per share — the better of the two. With $150,000 invested and accrued interest of $7,500 (at 5% for one year), you convert $157,500 into 157,500 preferred shares. At a $10 million post-money valuation, that represents approximately 1.575% of the company — before further dilution from the option pool.

7. Closing the Deal: Practical Steps and Timeline

A straightforward seed CLA with a single investor typically takes three to six weeks from term sheet to funded. Here is how that time breaks down.

Week 1–2: Term sheet and basic due diligence. Agree on the key economic terms (cap, discount, interest, maturity, MFN, pro-rata) in a non-binding term sheet. Simultaneously, conduct basic legal due diligence: verify the company is incorporated with the Israeli Companies Registrar (searchable at the Registrar's public database, *rasham.justice.gov.il*), review the articles of association, and check whether any existing shareholders have pre-emption rights (*zchut kadima*) or right-of-first-refusal clauses that could affect the investment.

Week 2–4: Legal drafting. Your Israeli attorney drafts or reviews the CLA. Key documents include: (1) the CLA itself; (2) a board resolution of the startup authorising the loan; (3) if required by the articles, a shareholder resolution; (4) representations and warranties by the company; and (5) a side letter if you are negotiating additional rights (information rights, board observer seat).

Week 4–5: Signing and regulatory steps. Both parties sign. If the CLA includes a charge, the startup's lawyer files Form 10 with the Companies Registrar within 21 days. You wire funds — typically to the startup's Israeli bank account in USD or NIS, depending on the agreement. Bring-in of foreign currency above $50,000 must be declared to the bank under Bank of Israel regulations, but there is no regulatory approval required for the transfer itself.

Ongoing: Post-investment compliance. The startup must file monthly withholding tax reports with the ITA if interest is payable, provide you with annual accounts under your contractual information rights, and notify you of any material events. You should calendar the CLA maturity date and the qualifying round threshold. If neither occurs, begin discussions about extension at least 60 days before maturity.

  • Total typical timeline from term sheet to funded: 3–6 weeks for a straightforward seed CLA with a single investor
  • Legal cost for investor's counsel: approximately $2,000–$5,000 for a standard CLA review and negotiation
  • Legal cost for company's counsel: approximately $1,500–$4,000 for drafting and resolutions
  • Registrar fees: NIS 990 for charge registration; NIS 620 for share allotment filing upon conversion
In Practice — Bank Transfer Compliance:

Israeli banks are required under the Prohibition on Money Laundering Law 2000 (*Hok Isur Halbanat Hon*) to verify the source of any incoming wire above approximately NIS 50,000 (roughly $14,000). Expect the startup's Israeli bank — commonly Bank Hapoalim, Bank Leumi, or Discount Bank — to request from the startup: a copy of the signed CLA, a declaration of the source of funds, and your passport details if you are a new foreign investor. This process typically takes 2–5 business days and should be planned for in the closing timeline.